{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T23:00:12Z","timestamp":1783983612990,"version":"3.55.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1093\/jac\/dkp128","type":"journal-article","created":{"date-parts":[[2009,4,17]],"date-time":"2009-04-17T00:45:37Z","timestamp":1239929137000},"page":"1272-1275","source":"Crossref","is-referenced-by-count":38,"title":["Temporal effects of antibiotic use and Clostridium difficile infections"],"prefix":"10.1093","volume":"63","author":[{"given":"Nathalie","family":"Vernaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsteen","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Leggeat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip","family":"Nathwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabby","family":"Philips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Bonnabry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Davey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,4,16]]},"reference":[{"key":"key\n\t\t\t\t20170511114326_DKP128C1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jac\/dkn199","article-title":"Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile","volume":"62","author":"Vernaz","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511114326_DKP128C2","author":"Edinburgh ISD (Information and Statistics Division), 2004","journal-title":"Scottish Health Services Costs 2003\/04"},{"key":"key\n\t\t\t\t20170511114326_DKP128C3","journal-title":"World Health Organization Collaborating Centre for Drug Statistics Methodology Guidelines for ATC Classification and DDD Assignment"},{"key":"key\n\t\t\t\t20170511114326_DKP128C4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ijantimicag.2006.10.020","article-title":"Point prevalence survey of antibiotic use in Scottish hospitals utilising the Glasgow Antimicrobial Audit Tool (GAAT)","volume":"29","author":"Seaton","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170511114326_DKP128C5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/096228029600500102","article-title":"Box-Jenkins modelling in medical research","volume":"5","author":"Helfenstein","year":"1996","journal-title":"Stat Methods Med Res"},{"key":"key\n\t\t\t\t20170511114326_DKP128C6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1086\/521255","article-title":"Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies","volume":"45","author":"Shardell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170511114326_DKP128C7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0924-8579(99)00135-1","article-title":"Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis","volume":"14","author":"Lopez-Lozano","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170511114326_DKP128C8","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bmj.328.7451.1297","article-title":"Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel model with practice and individual patient data","volume":"328","author":"Donnan","year":"2004","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170511114326_DKP128C9","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/519178","article-title":"Onset of symptoms and time to diagnosis of Clostridium difficile-associated disease following discharge from an acute care hospital","volume":"28","author":"Chang","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t20170511114326_DKP128C10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1086\/528813","article-title":"Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005","volume":"29","author":"Kutty","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"key\n\t\t\t\t20170511114326_DKP128C11","first-page":"332","article-title":"Out-patient and home-parenteral antibiotic therapy (OHPAT): evaluation of the impact of one year\u2019s experience in Tayside","volume":"57","author":"Nathwani","year":"1999","journal-title":"Health Bull"},{"key":"key\n\t\t\t\t20170511114326_DKP128C12","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1086\/521859","article-title":"Antimicrobial-associated risk factors for Clostridium difficile infection","volume":"46","author":"Owens","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170511114326_DKP128C13","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/jac\/dkh285","article-title":"Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea","volume":"54","author":"Wilcox","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511114326_DKP128C14","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/jac\/dki120","article-title":"Effects of piperacillin\/tazobactam on Clostridium difficile growth and toxin production in a human gut model","volume":"55","author":"Baines","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511114326_DKP128C15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1053\/jhin.2001.0951","article-title":"Antibiotic prophylaxis and the risk of Clostridium difficile-associated diarrhoea","volume":"48","author":"Harbarth","year":"2001","journal-title":"J Hosp Infect"},{"key":"key\n\t\t\t\t20170511114326_DKP128C16","author":"Glasgow Scottish Antimicrobial Prescribing Group, 2008","journal-title":"Guidance to Optimise Antibiotic Use and Reduce Clostridium difficile Associated Disease (CDAD) in Scottish Hospitals, Version 1"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/63\/6\/1272\/16862327\/dkp128.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T10:42:59Z","timestamp":1503484979000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkp128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,16]]},"references-count":16,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2009,4,16]]},"published-print":{"date-parts":[[2009,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkp128","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4,16]]}}}